CAPA In-vitro Oocyte Maturation
Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
In vitro oocyte maturation (IVM) is a mild-approach assisted reproductive technology (ART). Because of its simplicity, the more favorable financial implications (reduced cost) for patients, and the lower health risk profile of IVM compared to controlled ovarian stimulation (COS) in polycystic ovary syndrome (PCOS) patients, the use of IVM in selected patients may gain increasing interest. Besides its application in patients with polycystic ovaries, IVM technology may have a role in fertility preservation, where young girls and adult women are facing infertility due to gonadotoxic chemotherapeutic treatment.
Eligibility
Participation Requirements
Sex: Female
Maximum Age: 50
Healthy Volunteers: t
View:
• Patients aged from 0-50 years old
• Patients seek fertility preservation services
• Patients seek oocyte retrieval services
Locations
Other Locations
Hong Kong Special Administrative Region
Prince of Wales Hospital
RECRUITING
Hong Kong
Contact Information
Primary
Pui Wah Jacqueline Chung
jacquelinechung@cuhk.edu.hk
+852 3505 1537
Time Frame
Start Date: 2025-11-10
Estimated Completion Date: 2032-05-31
Participants
Target number of participants: 100
Treatments
Experimental: CAPA-IVM
In CAPA-IVM, the oocyte is treated and matured outside the woman's body, while in classical IVF, the patient is treated. As a consequence, patients undergoing CAPA-IVM are not confronted with the typical risks and burden of systemic ovarian stimulation.
Related Therapeutic Areas
Sponsors
Leads: Chinese University of Hong Kong